Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A U.S. Payer Perspective
PaperCitations, authors & open-access status
Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A U.S. Payer Perspective is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 29 citations, 2015 year and bronze oa status.
29
Citations
2015
Year
bronze
OA Status